This assay is to provide SW 780-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
SW 780
Target Cell Organism
Human
Target Cell Background
The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma.
Target Cell Alternative Name
SW-780, SW780
Related Diseases
Bladder Cancer
Research Area
Oncology
Assay Name
In Vivo Tumorigenesis Assay
Short Description
SW 780-cell based In Vivo Tumorigenesis Assay
Assay Description
Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.